Research ArticleBasic Science Investigation
Single-Dose Versus Fractionated Radioimmunotherapy: Model Comparisons for Uniform Tumor Dosimetry
Joseph A. O'Donoghue, George Sgouros, Chaitanya R. Divgi and John L. Humm
Journal of Nuclear Medicine March 2000, 41 (3) 538-547;
Joseph A. O'Donoghue
George Sgouros
Chaitanya R. Divgi


This is a PDF-only article. The first page of the PDF of this article appears above.
In this issue
Single-Dose Versus Fractionated Radioimmunotherapy: Model Comparisons for Uniform Tumor Dosimetry
Joseph A. O'Donoghue, George Sgouros, Chaitanya R. Divgi, John L. Humm
Journal of Nuclear Medicine Mar 2000, 41 (3) 538-547;
Jump to section
Related Articles
- No related articles found.
Cited By...
- Mathematical Modeling of Preclinical Alpha-Emitter Radiopharmaceutical Therapy
- MIRD Pamphlet No. 20: The Effect of Model Assumptions on Kidney Dosimetry and Response--Implications for Radionuclide Therapy
- Three-Dimensional Radiobiologic Dosimetry: Application of Radiobiologic Modeling to Patient-Specific 3-Dimensional Imaging-Based Internal Dosimetry
- Radioimmunotherapy of Prostate Cancer Using 90Y- and 177Lu-Labeled J591 Monoclonal Antibodies: Effect of Multiple Treatments on Myelotoxicity
- Dosimetry of Internal Emitters
- Low-Dose Radioimmunotherapy (90Y-PAM4) Combined with Gemcitabine for the Treatment of Experimental Pancreatic Cancer
- MIRD Pamphlet No. 19: Absorbed Fractions and Radionuclide S Values for Six Age-Dependent Multiregion Models of the Kidney
- Therapeutic Advantage of 90Yttrium- versus131Iodine-labeled PAM4 Antibody in Experimental Pancreatic Cancer